During the past decade, Sasebo Chuo Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sasebo Chuo Hospital" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "AbbVie" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Janssen Pharmaceutical K.K." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sasebo Chuo Hospital" #1 collaborator was "NPO International TRI Network" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sasebo Chuo Hospital" are "Rheumatoid Arthritis" (6 trials), "Systemic Lupus Erythematosus" (2 trials), "Acute Myocardial Infarction" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Sasebo Chuo Hospital" in a lesser frequency.

Most popular intervention types in "Sasebo Chuo Hospital" are "Drug" (10 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (1 trials), "Biolimus A9 eluting stents" (1 trials), "CP-690,550" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sasebo Chuo Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Sasebo Chuo Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Sasebo Chuo Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sasebo Chuo Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".